Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could probiotic sprays and drinks help kids beat pneumonia faster?

NCT ID NCT07399717

Disease control Sponsor: Anabio R&D Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 27, 2026 · Updated 3 times

Summary

This study tests whether adding probiotic nasal spray and oral probiotics to standard pneumonia treatment helps children aged 6 to 36 months recover faster. 330 children will be split into three groups: one getting a placebo, one getting probiotic nasal spray only, and one getting both nasal and oral probiotics. The goal is to see if probiotics reduce symptoms, hospital stays, and later recurrences of respiratory or stomach issues.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Probiotics (Bacillus subtilis, Bacillus clausii, Bacillus coagulans) as nasal spray and oral suspension
What this could lead to
If it works, this could offer a simple, low-cost way to speed up recovery from pneumonia in young children and reduce the chance of symptoms coming back.
What could go wrong
This is a small, early-stage trial with no phase designation, so results may not be conclusive. The probiotics are added to standard care, so any benefit may be modest and not generalizable to all children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 330 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Nov 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 36 months

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children (male/female) aged 6-36 months diagnosed and hospitalized for treatment for pneumonia. * Parents or guradians of the children agree to participate in the study, explain, and sign the research consent form. Exclusion Criteria: * Children who need ventilator support. * Children who have had rhinoplasty surgery, nasal ulcers, nasal polyps or any nasal deformity that affects the use of the study product. * Children who get transferred or leave the treatment unit (not for professional reasons). * Children who have experienced congenital immunodeficiency or infectious disease (eg, HIV). * Children who are concurrently participating in another clinical trial or participated in a clinical trial within 30 days before selection. * Children who are under long-term medication (more than 7 consecutive days) within 30 days before selection. * Children with allergy or hypersensitivity to any ingredient of the study product.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pneumonia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

pneumonia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pneumonia Pneumonia in children

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Phu Tho Provincial Obstetrics and Pediatrics Hospitals

    Phú Thọ, Vietnam

More trials for these conditions

Other studies related to the condition(s) this trial covers.